SARS-CoV-2 infection further aggravates this ACE2/Angiotensin 2 imbalance, which could suggest a specific role for these pre-existing conditions as risk factors for COVID-19 morbidity and mortality. This evidence concerns the gene ACE2 and COVID-19.